Autolus Therapeutics (AUTL)
1.73
0.00 (0.00%)
At close: Mar 03, 2025, 12:11 PM
Autolus Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Revenue | 1.7M | 6.19M | 2.33M | 242K | 2.91M | 1.05M | 1.69M | 1.21M | 94.11K |
| Cost of Revenue | 6.57M | 137.22M | 128.65M | 134.89M | 4.61M | 48.3M | 1.01M | 478K | n/a |
| Gross Profit | -4.87M | -131.03M | -126.32M | -134.65M | -1.7M | -47.25M | 684K | 734K | 94.11K |
| Operating Income | -195.03M | -163.78M | -164.21M | -168.15M | -137.86M | -57.53M | -23.42M | -14.38M | -8.11M |
| Interest Income | 13.51M | 1.71M | 262K | 536K | 2.54M | 4.12M | 84K | 75K | 7.93K |
| Pretax Income | -208.4M | -173.21M | -165.99M | -166.26M | -139.01M | -36.33M | -23.38M | -14.33M | -8.1M |
| Net Income | -208.38M | -148.84M | -142.1M | -142.09M | -123.85M | -31.11M | -19.73M | -12.55M | -7.46M |
| Selling & General & Admin | 46.74M | 31.9M | 31.86M | 34.97M | 39.45M | 16.85M | 9.1M | 5.15M | 6.04M |
| Research & Development | 149.98M | 141.99M | 134.79M | 134.89M | 105.42M | 24.64M | 16.01M | 10.44M | 2.17M |
| Other Expenses | n/a | -166K | -145K | -1.47M | 4.51M | 3.97M | -46K | -26K | n/a |
| Operating Expenses | 1.7M | 173.72M | 166.65M | 168.39M | 144.87M | 41.48M | 25.11M | 15.59M | 8.2M |
| Interest Expense | 45.07M | 8.9M | 1.1M | n/a | n/a | 12.67K | n/a | n/a | n/a |
| Selling & Marketing Expenses | 1.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 196.73M | 173.72M | 166.65M | 168.39M | 144.87M | 41.48M | 25.11M | 15.59M | 8.2M |
| Income Tax | -19K | -24.37M | -23.89M | -24.16M | -15.16M | -5.21M | -3.65M | -1.78M | 634.51K |
| Shares Outstanding (Basic) | 173.94M | 94.99M | 72.08M | 51.56M | 43.07M | 31.56M | 13.78M | 13.78M | 13.78M |
| Shares Outstanding (Diluted) | 173.94M | 94.99M | 72.08M | 51.56M | 43.07M | 31.56M | 13.78M | 13.78M | 13.78M |
| EPS (Basic) | -1.2 | -1.57 | -1.97 | -2.76 | -2.88 | -0.99 | -1.43 | -0.91 | -0.54 |
| EPS (Diluted) | -1.2 | -1.57 | -1.97 | -2.76 | -2.88 | -0.99 | -1.43 | -0.91 | -0.54 |
| EBITDA | -156.77M | -135.54M | -132.01M | -160.51M | -134.4M | -50.32M | -22.41M | -13.9M | -4.47M |
| Depreciation & Amortization | 6.57M | 7.42M | 8.55M | 5.75M | 4.61M | 1.71M | 1.01M | 478K | 3.64M |